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ABSTRACT: 
Folic acid is a very important vitamin. It is needed by cells for various physiological 
functions. It plays an important role in growth and multiplication of cells and therefore is needed 
very much by cancerous cells. One of the ways folate reaches the cells is the folate receptor 
mediated endocytosis. Therefore folate binding proteins are abundant on cancerous cells. 
Clinical trials proved that the folate receptor targeted drug delivery is very promising to increase 
the drug exposure to malignant cells and to reduce the toxicity to healthy cells. It was recently 
discovered that folate receptor is also over expressed on activated macrophages which could 
contribute to diseases such as crohn’s disease, rheumatoid arthritis, lupus, inflammatory 
osteoarthritis, vasculitis, diabetes, ischemia, reperfusion injury, sarcoidosis, glomerulonephritis, 
psoriasis and sjogren’s disease.2-5,8 Therefore folate receptor targeted drug delivery would also 
be beneficial for   above diseases. Folic acid needs a carrier to take it to folate receptor. Serum 
Albumin is found to be suitable carrier for folate.  In this project we make several conjugates of 
Folate-BSA and determine the simple way of making Folate-BSA for commercial use. The 
project also focuses on determining the degree of labeling of Folate on BSA. Finally Folate-BSA 
is labeled with dyes fluorescein and Rhodamine which can be used in future studies as 
fluorescent imaging agents.
25-26
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INTRODUCTION: 
In this project, we prepare different fluorescein and Rhodamine folate-BSA conjugates. 
We discovered a method to prepare folate-BSA for commercial purposes. The conjugates are 
used as imaging agents, as a surface for adsorption of gold nanoparticles, to discover effective 
folate receptor targeted drug delivery many malignancies (in chemotherapy particularly). 
Folic acid:  
Folic acid (Fig 1) is a water soluble vitamin B9. Folic acid is the man made form of 
Folate which occurs naturally in the body. It is used for various physiological functions. It is very 
important for cell growth and maintenance. It also acts as a coenzyme for the synthesis of DNA 
and RNA. It also plays important role in the rapid growth and multiplication of cells in the fetus. 
Deficiency of folate in pregnant woman will lead to child birth defects. Amino acids histidine, 
serine, glycine and methionine require folate for metabolism. Unavailability of folate for 
methionine metabolism may lead to excess amounts of homocysteine which may lead to heart 
problems. Folate is also required for the proper maintenance of nervous system. In case of folate 
deficiency, of all, nucleic acids synthesis is the most affected process which may lead to cancer.
1-
3, 11
    
Folate Receptor: 
There are two mechanisms for the transport of folate into cells: 
1. Reduced folate carrier (RFC) (Fig-2): This system has high affinity for reduced folate. The 
RFC produces an electrochemical potential difference for folates across the cell membranes. 
RFC is a transmembrane protein. It comprises of 591 amino acid residues and it uses an 
anion exchange mechanism to transport the folates into cells.
3-6 
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2. Endocytosis of GPI linked membrane Folate receptor alpha: The Folate receptor internalizes 
the bound Folate or Folate conjugated compounds via receptor mediated endocytosis. The 
folates are then is retained in the cytoplasm by polyglutamation. This mechanism has high 
affinity for oxidized folate, folic acid. Figure 3 explains the transport of folate conjugates. On 
the plasma membrane there are small non-clathrin coated invaginations called caveolae 
which serve to concentrated folates. The caveolae seal and acidification of the caveolae 
results in the dissociation of the folates from MFRα. Folates are then translocated into the 
cytoplasm by putative carrier protein.
8-12
  
BSA: 
 
Serum albumin is a protein in plasma. The concentration is around 5g/100ml. It 
contributes a total of 80% to the colloid osmotic blood pressure. It is mainly responsible for 
maintaining the blood pH. The precursor of the albumin is the preproalbumin synthesized by 
liver. From preproalbumin the signal peptide is removed to form proalbumin. The six-residues of 
propeptide are removed from the new N-terminus of the proalbumin and the final product is the 
albumin. The half-life of albumin is 19 days.  In general albumin has tryptophan and methionine. 
It has high amounts of cystine, charged amino acids, aspartic and glutamic acids, lysine and 
arginine.
23-26 
Folate conjugates: 
Folate can be conjugated with variety of physiologically active compounds. Some of 
them are immunotherapeutic agents, protein toxins, chemotherapeutic agents, drug nanoparticles, 
liposomes, drug carriers etc. In this report we describe the attachment of folate to BSA. We make 
several different concentrations of folate-BSA. Folate BSA can be used as an imaging agent. 
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Imaging agents are chemicals made to detect if a tissue in the body is either benign or 
malignant.
7
  
In United States, the second leading cause of death is cancer. Research was done and is 
being done to find a way to treat cancer. As a result of this there are many treatments (often not 
complete) available today. The most efficient and common one is the chemotherapy. In 
chemotherapy the number of cells killed is directly proportional to the amount of drug the cells 
are exposed to. But then high doses of the drug exposure are hindered because of the poor 
selectivity and the severe toxicity it causes to the normal cells. Therefore research is being 
progressed towards the tumor specific treatment. 
The ideal solution to achieving tumor specific treatment is to deliver biologically 
effective doses of anticancer agents to the tumor tissues with very high specificity. Efforts were 
made to develop selective drug by conjugating anti-cancer drugs to harmones, antibodies and 
vitamin derivatives. Folic acid which is of low-molecular weight promises as a tumor-homing 
agent. Folate also happens to be a high affinity ligand which increases differential specificity of 
conjugated anti-cancer drugs by targeting Folate receptor-positive cancer cells.
4-6
  
Research has shown that FR level and density accumulates in the tumor cells (Fig-4) and 
therefore it can be hypothesized that Folate conjugated anti-cancer drugs will improve drug 
selectivity and decrease the negative side effects on the normal cells. By considering the above it 
can be said that undestructive delivery of macromolecules to the living cells is difficult but is 
absolutely necessary in cancer treatment. Since the natural endocytosis pathway for vitamin 
Folate is known, it can be exploited to deliver the macromolecules if the macromolecules are 
first covalently linked to Folate. For example, Folate conjugated ribonuclease, horse radish 
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peroxidase, IgG or ferritin. Treatment of cells with above allowed delivery of more than 10
6 
copies of the macromolecules within a 2 hour period.
10
 Drug coupling to inert carriers may be 
designed with the only purpose of prolonging the permeance in blood to get a passive 
distribution into some tissues and also conjugating provides a targeting system that selectively 
recognizes specific biological structures. 
Fluorescein Isothiocyanate and Rhodamine Dye: 
Fluoroscein and Rhodamine are fluorescent dyes used to trace the flow of proteins, drugs 
or imaging agents in the living cells. Rhodamine is red in color and Fluoroscein orange. They 
impart pink and yellow color respectively to Folate-BSA. The absorption maxima of fluorescein 
is 494nm and emission maxima is 521nm. For Rhodamine, the absorption maximum is 570nm 
and emission maxima at 590nm. 
Folate conjugates labeled with FITC or Rhodamine can be used in imaging the cancerous 
growth. Targeted delivery of imaging agents can be achieved by use of folate conjugates and the 
stage of the disease can be identified.  Folate conjugates can be attached to dyes and drugs. 
Folate-BSA can also be used as adsorption surface in synthesis of Gold nanoparticles. This 
adsorption is explained in figure 4. Gold has high light scattering and absorbing ability. The 
detection of cancer would be much easier when gold nanoparticles are made using the folate-
BSA as the surface for adsorption. Folate conjugates can also to be attached to drugs to provide 
targeted drug delivery in case of cancer.
3-7 
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MATERIALS AND METHODS: 
Materials and Reagents: 
 
Albumin from Bovine serum A4503-10G Lot # 029k1394 p code: 1000528230; ≥ 96% (agarose 
gel electrophoresis) powder lyophilized 5.0-5.6; 1 % w/v in H2O, Phosphate Buffered saline 
without calcium and magnesium Cat No: 21-040-CV Lot No: 21040174 exp 07/11 volume 
500ml, Biocinchonic acid solution (10ml) from Sigma Life science B9643-1L, Copper sulfate 
(cu2so4) 4% w/v prepared from copper (II) sulfate pentahydrate, EDC, N-((3-
Dimethylaminopropyl)-N-ethyl carbodamide hydrochloride CAS No: 25952-53-8 Mfg by Sigma 
Aldrich, Eppendorfs fisher Brand premium 1.5 ml MCT Graduated natural Cat No: 05-408-129 
Lot No: 10110134, Beckman VWR Centrifuge filter Modified PES 3k 500µl Low protein 
Binding, Epoch plate reader, mini-PROTEAN
R 
TGX
TM 
catalog # 456-1096 4-20% 15 well comb 
15µl, Precision Plus protein
 TM 
catalog # 161-0373 500 µl, Laemmli sample buffer 30ml catalog 
# 161-0737 by Bio-Rad laboratories. 
Methodology: 
Preparation of Protein samples:  
The concentrations prepared in step 5 in the flow chart are shown below: 
a.  5 fold: 500µl of BSA+PBS, 37µl of FA+EDC and 463µl of PBS 
b. 10 fold: 500µl of BSA+PBS, 75µl of FA+EDC and 425 µl of PBS 
c. 20 fold: 500µl of BSA+PBS, 150µl of FA+EDC and 350 µl of PBS 
d. 40 fold: 500µl of BSA+PBS, 300µl of FA+EDC and 200µl of PBS 
11 
 
 
1
• Preperation of BSA solution: weigh 70mg of BSA and mix it in 7ml of PBS 
2
• Preparation of EDC solution in folic acid of pH 7.4: weigh 90mg of EDC and dissolved in 
4.5ml of folic acid and adjust the pH to 7.4 using Hcl and NaOH. 
3
• Preparation of the dilutions: The volume used for different dilutions is as shown below.
4
• Label 12 different eppendorfs (fig-5)
5
• Prepare different concentrations 5,10,20,40 fold in eppendorfs.
6
• Stir all the samples continuously for 4 hrs using a magnetic stirrer (Fig-6). 
7
• Take 500µl of all samples from eppendorfs and transfer into spin filters
8 • Centrifuge the sample in spin filters at 8400 RCF for 12 min (Fig-7).
9
• Centrifuge for 5 times that is the protein is washed 5 times.
10
• After 5 washes, resuspend the protein in each spin filter into 500 µl PBS. 
11 • Transfer the above solution into new labeled eppendorfs for further analysis.
12
• The BSA-Folate is now labeled with Fluoroscein and Rhodamine. 
12 
 
Different concentrations of Folate, BSA and EDC are made. EDC is used as a coupling agent 
(Fig-8). 
Preparation of BSA standards: 
 
BSA standards are prepared according to the thermo scientific instructions as follows: 
 
Vial Diluent 
Volume 
(μL) 
BSA Source 
and Volume 
(μL) 
Concentration 
(μg/mL) 
A  0  500 of stock  2,000  
B  125  375 of stock  1,500  
C  200  200 of stock  1,000  
D  200  200 of vial B  750  
E 200 200 of vial C 500 
F  200  200 of vial E  250  
G  200  200 of vial F  125  
 
The standard BSA curve is shown in figure 9. 
 
Folate-BSA labeling with Fluorescein and Rhodamine:  
 
Samples 10 fold and 20 fold are taken and are centrifuged to remove the PBS. To the 
washed protein 0.5ml of sodium carbonate is added. The protein in sodium carbonate is taken in 
a different tube. To this add 10µl of fluorescein in DMSO (This is prepared by adding 3.25µl of 
the dye in 250µl of DMSO). The protein is then washed with DMSO and is resuspended in PBS. 
Fluoroscein and Rhodamine are weighed and added to the sample and stirred for four hours 
using a magnetic stirrer. After adding the dye, it is allowed to mix overnight. The dye labeled 
protein samples are again spin filtered and washed with PBS 5 times. The BCA assay is done on 
13 
 
the samples. Degree of labeling is calculated. Fluoroscein imparts yellow color and Rhodamine 
violet color to the protein BSA samples. (Fig-10)  
INSTRUMENTATION: 
UV-VIS Plate reading: 
 
 In a UV-VIS plate reader, take 100µl of PBS as blank in A1 and A2 wells.  
 In B1 and B2 wells, take 100µl of the washed pure protein 
 Read at 280nm and 363nm wavelength at corrected path length. 
BCA Analysis: 
BSA standards are prepared as per the instructions given in the thermo scientific.  
1. BCA standard solution is prepared by mixing 200µl of cu2so4 in 10ml of BCA reagent.  
2. 10µl of standards in triplicates and 10µl of samples in duplicates are added in the wells of 
the BCA plate. (Fig 11)  
3. To all the above wells 200µl of BCA reagent is added. 
4. The plate is covered with par film and is incubated for 30 minutes. 
5. BCA analysis is run and plate is read at 562nm and the data is recorded.     
For those protein samples labeled with Fluoroscein, both uv-vis and BCA readings are 
taken but those samples with Rhodamine, only uv-vis is done because the emission 
wavelength of Rhodamine is around 562nm which make it overlap with BCA readings taken 
at 582nm.  
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Gel electrophoresis (fig-12) was done on the protein samples based on Bio Rad. From the 
gel we could conclude that there were no impurities (fig-13) since there were no large 
aggregates formed. A standard curve of different molecular weights is calculated (fig-14) 
RESULTS AND DISCUSSION: 
Preparation of Folate-BSA:  
 
Different approaches were tried in preparation of Folate-BSA. EDC was used as a 
binding agent. 10µl of EDC is added to 5mg of BSA in an eppendorf and is stirred overnight for 
24 hours with a magnetic stirrer and then the centrifugation is done 5 times. But this showed 
protein precipitation in the 40 fold and the 60 fold. Even when the stirring time was reduced 
from overnight or 24 hrs to 6hrs time, the protein in 40 fold and 60 fold concentrations 
precipitated. And when 2hrs time for stirring was used the 60 fold protein concentration still 
precipitated. Therefore finally a 4hr stirring time was determined as optimum. The 60 fold still 
showed precipitation but was much less relatively.  To make the preparation method easy, the 
compounds were mixed in different order. First BSA and EDC were weighed in equal quantities 
and then folate and PBS were added. This resulted in the formation of crystals in the 40 and 60 
fold and the dissolving process was also not that good. After several trials, it was found out that 
EDC dissolved well in Folate and BSA dissolved in PBS and both mixed well. Finally to make 
the preparation much easier, EDC in folate and BSA in PBS were prepared in bulk and mixed in 
quantities as per the calculations and were made up with PBS. 
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Degree of labeling of Folate-BSA: 
         The binding of Folate-BSA was calculated using the following spreadsheet:   
Protein BCA Reading Molarity Molarity x DF Abs at 363nm Molarity
5 Fold 1 0.131 1.97E-06 1.97E-05 0.73 6.94E-05 3.519253278
5 Fold 2 0.082 1.23E-06 1.23E-05 0.64 5.21E-05 4.216666275
5 Fold 3 0.337 5.08E-06 5.08E-05 0.94 0.00010993 2.166029033
10 Fold 1 0.454 6.84E-06 6.84E-05 1.68 0.00025265 3.695172877
10 Fold 2 0.359 5.41E-06 5.41E-05 1.63 0.00024301 4.494645203
10 Fold 3 0.404 6.08E-06 6.08E-05 1.66 0.00024879 4.089099363
20 Fold 1 0.388 5.84E-06 5.84E-05 3.61 0.00062488 10.69381344
20 Fold 2 0.332 0.000005 0.00005 3.11 0.00052845 10.56894889
20 Fold 3 0.34 5.12E-06 5.12E-05 2.51 0.00041273 8.060355097
40 Fold 1 0.123 1.85E-06 1.85E-05 3.02 0.00051109 27.59053241
40 Fold 2 0.245 3.69E-06 3.69E-05 4.41 0.00077917 21.1171157
Degree Of Labeling
 
      Moles of folate per mole of BSA= No. of moles of Folate/No. of moles of BSA   
In the above calculations, Volume used is 1ml, Dilution factor is 10, Molecular weight of BSA is 
66400 and molar extinction coefficient of Folate is 5185. It was calculated as shown in Fig-11 
Labeling of Folate-BSA with fluorescein and Rhodamine: 
With the molar extinction coefficient of 70,000 M
-1
cm
-1
, it was calculated that there were ~ two 
fluorescein molecules attached to each BSA. Rhodamine molar extinction coefficient is 
85,000M
-1
cm
-1
.
 
There was ~ 1 Rhodamine attached to each BSA.  
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CONCLUSION: 
A simple way of preparation of different protein concentrations is determined. It is found 
out that the 10 and 20 fold concentration is the optimum concentration for Folate BSA. 
Concentrations above 40 fold showed precipitation. The degree of Folate labeling on BSA is 
determined to be about roughly double for each concentration increased. Fluorescein and 
Rhodamine dyes are attached to Folate BSA and it is found that on an average, two fluorescein 
molecules and one Rhodamine molecule are attached to each BSA molecule. In future, research 
can be focused on preparing Folate BSA for commercial purposes which can in turn be tested for 
use with gold nanoparticles, as imaging agents, targeted drug deliver etc.      
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Figure-1 Structure of Folic acid 
 
 
Figure -2: RFC mediated transport of folate into cells. (Medscape) 
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Figure 3: Folate receptor mediated endocytosis of folic acid conjugate. Different folate 
conjugates bind to the folate receptor with high affinity and are then internalized into endosomes. 
(Low, Henne, Accounts of Chemical Research). 
 
                   
Reduced folate carrier in normal cells.                                 alpha-FR in malignant cells. 
Figure-4: Comparison of alpha-FR on normal and malignant cells. (Endocyte Inc.) 
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Figure 4: Diagrammatic representation of adsorption of Folate BSA on gold surface.   ( Walter 
A. Henne,
†
 Derek D. Doorneweerd, Folate binding detection by enhance quartz balance.)                   
 
 
Figure-5: Labeling of eppendorfs for 5 fold, 10 fold, 20 fold, 40 fold, 60 fold.  
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Figure-6 Mixing of all the samples usig a magnetic stirrer. 
 
 
 
Figure-7: Beckman Centrifuge used to wash the protein in spin filters.  
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Figure-8: schematic representation of EDC coupling. 
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Figure -9: BSA standard Curve 
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Figure -10: 10 fold and 20 fold Folate-BSA after adding Fluoroscein and Rhodamine.   
 
 
                  
Figure-11: BCA analysis for blank, BCA standards and protein standards. 
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.  
Figure-12: Gel electrophoresis of the Folate-BSA protein sample. 
 
                    
Figure 13: Distance migrated by the proteins on a gel 
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Figure -14: Calculation of molar extinction coefficient. 
 
 
 
 
 
 
 
 
 
